Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-03-02

FDA Approved: ARFORMOTEROL TARTRATE INHALATION SOLUTION — Original Application (Ritedose Pharmaceuticals, LLC)

View source ↗

Summary

The FDA approved an original application for ARFORMOTEROL TARTRATE INHALATION SOLUTION (arformoterol tartrate inhalation solution) by Ritedose Pharmaceuticals f…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ARFORMOTEROL TARTRATE INHALATION SOLUTION (arformoterol tartrate inhalation solution)

Snippet

ORIG AP for ARFORMOTEROL TARTRATE INHALATION SOLUTION (ARFORMOTEROL TARTRATE INHALATION SOLUTION)